BioHarvest Sciences Current Ratio 2020-2024 | BHST
BioHarvest Sciences current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| BioHarvest Sciences Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$0.01B |
$0.01B |
1.04 |
| 2024-03-31 |
$0.01B |
$0.01B |
0.57 |
| 2023-12-31 |
$0.01B |
$0.03B |
0.34 |
| 2023-09-30 |
$0.01B |
$0.02B |
0.32 |
| 2023-06-30 |
$0.01B |
$0.01B |
0.38 |
| 2023-03-31 |
$0.00B |
$0.01B |
0.32 |
| 2022-12-31 |
$0.00B |
$0.01B |
0.38 |
| 2022-09-30 |
$0.01B |
$0.01B |
0.50 |
| 2022-06-30 |
$0.00B |
$0.01B |
0.69 |
| 2022-03-31 |
$0.00B |
$0.00B |
1.40 |
| 2021-12-31 |
$0.01B |
$0.00B |
1.94 |
| 2021-09-30 |
$0.01B |
$0.00B |
3.49 |
| 2021-06-30 |
$0.01B |
$0.00B |
1.85 |
| 2021-03-31 |
$0.01B |
$0.01B |
0.94 |
| 2020-12-31 |
$0.00B |
$0.00B |
1.18 |
| 2020-09-30 |
$0.00B |
$0.00B |
2.54 |
| 2020-06-30 |
$0.00B |
$0.00B |
1.07 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| 2019-06-30 |
$0.00B |
|
0.00 |
| 2019-03-31 |
$0.00B |
$0.00B |
32.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
